Rajiv Patni Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Rajiv Patni.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Rajiv Patni. Rajiv Patni is EVP, CMO in PORTOLA PHARMACEUTICALS INC ($PTLA) and Chief Development Officer in Ocera Therapeutics, Inc. ($TZYM) and Chief Medical Officer in Adamas Pharmaceuticals Inc ($ADMS).
Latest Insider Trading Transactions of Rajiv Patni
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADMS, TZYM, PTLA
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 02 2020 | PTLA | PORTOLA PHARMACEUT ... | Patni Rajiv | EVP, CMO | Option Exercise | D | 0.00 | 35,000 | 0 | 0 | |
| Jul 02 2020 | PTLA | PORTOLA PHARMACEUT ... | Patni Rajiv | EVP, CMO | Option Exercise | D | 10.11 | 125,000 | 1,263,750 | 0 | |
| Apr 10 2019 | ADMS | Adamas Pharmaceuti ... | Patni Rajiv | Chief Medical Offic ... | Option Exercise | A | 6.81 | 60,000 | 408,600 | 60,000 | |
| Apr 10 2019 | ADMS | Adamas Pharmaceuti ... | Patni Rajiv | Chief Medical Offic ... | Grant | A | 0.00 | 30,000 | 0 | 49,141 | 19.1 K to 49.1 K (+156.73 %) |
| Mar 21 2019 | ADMS | Adamas Pharmaceuti ... | Patni Rajiv | Chief Medical Offic ... | Sell | S | 8.00 | 2,374 | 18,992 | 19,141 | 21.5 K to 19.1 K (-11.03 %) |
| Mar 22 2018 | ADMS | Adamas Pharmaceuti ... | Patni Rajiv | Chief Medical Offic ... | Sell | S | 25.94 | 1,252 | 32,477 | 21,515 | 22.8 K to 21.5 K (-5.50 %) |
| Mar 22 2018 | ADMS | Adamas Pharmaceuti ... | Patni Rajiv | Chief Medical Offic ... | Sell | S | 25.94 | 1,252 | 32,477 | 21,515 | 22.8 K to 21.5 K (-5.50 %) |
| Mar 09 2018 | ADMS | Adamas Pharmaceuti ... | Patni Rajiv | Chief Medical Offic ... | Option Exercise | A | 25.66 | 54,750 | 1,404,885 | 54,750 | |
| Mar 09 2018 | ADMS | Adamas Pharmaceuti ... | Patni Rajiv | Chief Medical Offic ... | Grant | A | 0.00 | 9,125 | 0 | 22,767 | 13.6 K to 22.8 K (+66.89 %) |
| Mar 22 2017 | ADMS | Adamas Pharmaceuti ... | Patni Rajiv | Chief Medical Offic ... | Sell | S | 17.04 | 733 | 12,490 | 13,642 | 14.4 K to 13.6 K (-5.10 %) |
| Jan 20 2017 | ADMS | Adamas Pharmaceuti ... | Patni Rajiv | Chief Medical Offic ... | Option Exercise | A | 16.61 | 41,250 | 685,163 | 41,250 | |
| Jan 20 2017 | ADMS | Adamas Pharmaceuti ... | Patni Rajiv | Chief Medical Offic ... | Grant | A | 0.00 | 6,875 | 0 | 14,375 | 7.5 K to 14.4 K (+91.67 %) |
| Mar 08 2016 | ADMS | Adamas Pharmaceuti ... | Patni Rajiv | Chief Medical Offic ... | Option Exercise | A | 13.66 | 45,000 | 614,700 | 45,000 | |
| Mar 08 2016 | ADMS | Adamas Pharmaceuti ... | Patni Rajiv | Chief Medical Offic ... | Grant | A | 13.66 | 7,500 | 102,450 | 7,500 | 0 to 7.5 K |
| Jun 09 2015 | ADMS | Adamas Pharmaceuti ... | Patni Rajiv | Chief Medical Offic ... | Option Exercise | A | 19.14 | 120,000 | 2,296,800 | 120,000 | |
| May 07 2015 | TZYM | Ocera Therapeutics ... | Patni Rajiv | Chief Development O ... | Buy | P | 3.97 | 5,050 | 20,049 | 5,050 | 0 to 5.1 K |
| Sep 02 2014 | TZYM | Ocera Therapeutics ... | Patni Rajiv | Chief Development O ... | Option Exercise | A | 6.03 | 20,000 | 120,600 | 20,000 | |
| Sep 02 2014 | TZYM | Ocera Therapeutics ... | Patni Rajiv | Chief Development O ... | Option Exercise | A | 6.03 | 20,000 | 120,600 | 20,000 | |
| Sep 02 2014 | TZYM | Ocera Therapeutics ... | Patni Rajiv | Chief Development O ... | Option Exercise | A | 6.03 | 250,000 | 1,507,500 | 250,000 |
Page: 1